Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2017-09-15
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammation, Iron Deficiency and Anaemia Study 1
NCT04097639
Iron Absorption From Tef-injera in Women of Reproductive Age
NCT01687062
Iron Homoeostasis in Inflammation
NCT02155114
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient
NCT06986837
Anemia of Inflammation: Investigation on Impaired Iron Regulation in Acutely Ill Patients and Their Clinical Outcome
NCT01589874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-anemic women
Dultavax and Vaxigrip
All the women got an influenza/DTP vaccine in order to induce acute inflammation
anemic women
anemia due to iron deficiency
Dultavax and Vaxigrip
All the women got an influenza/DTP vaccine in order to induce acute inflammation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dultavax and Vaxigrip
All the women got an influenza/DTP vaccine in order to induce acute inflammation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* body weight \<70kg
* either non-anemic (Hb\>12.5g/dl) or anemic (Hb between 8-12 g/dl and ferritin \<15ng/ml)
Exclusion Criteria
* chronic disease
* smoking
* inflammation defined as CRP\<5mg/L; AGP\<1g/L
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ibn Tofail University-CNESTEN
UNKNOWN
Swiss Federal Institute of Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Michael B. Zimmermann
Prof. Dr. med.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ibn Tofail University-CNESTEN
Rabat, , Morocco
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMILE Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.